If you've searched for GLP-1 weight loss options online, you've almost certainly run into Ro and Hims. Both built large telehealth businesses around weight loss, and both show up near the top of search results for nearly every GLP-1 keyword. That makes them an obvious starting point for comparison, but the two platforms, and the market around them, have shifted quite a bit recently.

Here's how Ro and Hims actually compare right now, and why a lot of people end up choosing Shed instead once they look past the name recognition and see what's actually included in the program.

The Short Answer

Ro and Hims are large, well-known platforms, but scale isn't the same thing as fit. Both were built to serve as many patients as possible at once, which shows up in thinner, more transactional care: rotating providers, coaching as a paid add-on if it's offered at all, and a narrower set of formulation options if a standard injection doesn't work for you. 

Shed was built the other way around, starting from the provider relationship and the coaching, then adding the prescription on top. For most people comparing these three options side by side, that difference in structure, not just the medication itself, is what ends up mattering most.

What Do Ro and Hims Offer for GLP-1 Weight Loss?

Both Ro and Hims are large direct-to-consumer telehealth companies that expanded aggressively into GLP-1 weight loss over the past few years. The general model is similar for both: an online intake questionnaire, a provider review, and a prescription shipped to your door if you're approved.

Where they've started to diverge is in how much of their weight loss business still runs through compounded medication. Since semaglutide and tirzepatide came off the FDA's drug shortage list in late 2024 and early 2025, compounding these drugs is no longer permitted just because it's cheaper, only when a patient has a documented clinical need an FDA-approved product can't meet. That single regulatory shift has reshaped both companies' offerings.

How Hims Has Changed Its GLP-1 Program

Hims built a large part of its early weight loss growth around compounded semaglutide. That changed in 2026, when Hims settled with Novo Nordisk and moved away from broad compounded semaglutide for new patients. Its current model leans on a wider set of FDA-approved GLP-1 options, with compounded medication offered only in the limited cases where a provider determines it's clinically necessary.

How Ro's GLP-1 Program Compares

Ro has continued offering compounded semaglutide and, in some cases, compounded tirzepatide, structured around provider check-ins and dose titration alongside nutrition and lifestyle guidance. Ro's program has also drawn regulatory attention in 2026 over how compounded medications were marketed relative to brand-name products, a reminder that this is a fast-moving regulatory space worth watching regardless of which provider you choose.

Ro vs. Hims vs. Shed: How the Models Compare

‍

On paper, the core medical model looks similar across all three: an intake, a provider, a prescription. But the table above is really where the decision gets made. Ro and Hims are competitive on the medication itself, that part of the market has become fairly commoditized, but Shed is the only one of the three that includes coaching, a consistent provider, formulation flexibility, and transparent pricing as a standard part of the program rather than something you have to ask for, upgrade to, or hope stays consistent from month to month.

Which Provider Fits Which Type of Patient?

The right answer here genuinely depends on what you're optimizing for, so it's worth thinking through where you fall, though for most of these scenarios, Shed ends up being the stronger fit once you factor in what's actually included.

• If brand recognition and scale matter most to you: Ro and Hims are both large, well-funded companies with broad medication catalogs and years of operating history. That size comes with a tradeoff, though, larger platforms tend to mean less consistent provider relationships and more of your program handled by whichever rotating staff is available that week.
• If you want the widest range of FDA-approved brand options: Hims' 2026 shift toward a broader assortment of FDA-approved GLP-1s is a step in the right direction, but Shed offers the same access to brand-name Ozempic, Wegovy, Zepbound, and Mounjaro without giving up the coaching and continuity that Hims still treats as optional extras.
• If you're comparing based on what's included beyond the prescription: This is where Shed pulls ahead clearly. Health coaching and a named care team are built into every plan from day one, not offered as a separate upsell you have to notice and add on.
• If you have a documented reason a standard product doesn't work for you: All three providers can discuss compounded formulations, but Shed also offers non-GLP-1 alternatives like combination oral medications, giving you more paths forward if a GLP-1 isn't the right fit.

What Should Actually Drive Your Decision?

• How the provider handles compounding today: Ask directly whether you're being offered an FDA-approved medication or a compounded one, and if compounded, what the documented clinical reason is. This should be a straightforward answer, not a sales pitch.
• What's included beyond the prescription: Health coaching, provider access between visits, and dose adjustment support all affect how sustainable the program feels over time.
• Pricing transparency: Look for a published monthly price rather than a starting rate that changes once you're a few months in.
• Formulation flexibility: If needles aren't for you, or a standard dose doesn't fit your situation, it's worth asking what alternatives are available.

Where Shed Fits In (and Why It's Often the Better Choice)

Shed isn't trying to be the biggest name in GLP-1 telehealth, and that's the whole point. Ro and Hims were both built to serve as many patients as possible, which is exactly why coaching, provider consistency, and formulation flexibility tend to fall away as add-ons instead of standards. Shed was built in the opposite direction, starting from the provider relationship first and adding the prescription on top of it, not the other way around.

In practice, that means the weight loss programs come with a named provider and care team, transparent pricing published upfront instead of a starting rate that shifts later, and health coaching included from day one rather than something you have to ask for. Shed also offers non-GLP-1 alternatives like metformin, naltrexone, and topiramate for people who need a different approach, something neither Ro nor Hims prioritizes to the same degree.

For patients who've tried a larger platform like Ro or Hims and felt like just another account number in the system, that structural difference is usually what they notice first after switching, more direct provider access, more consistent follow-up, and a program that doesn't ask you to pay extra just to get the support that should have come standard.

If cost is the main factor in your decision, it's also worth reading about the cheapest way to get GLP-1 medications without insurance. Manufacturer self-pay pharmacy programs now often beat compounded pricing across every provider, Shed included, which means the medication cost gap between Shed, Ro, and Hims has narrowed considerably, making the coaching, continuity, and transparency Shed includes even more of a deciding factor.

What About Switching Providers Later?

It's worth knowing upfront that you're not locked into whichever provider you choose first. Switching between telehealth platforms is generally straightforward, since your medical history and current prescription can be shared with a new provider during their intake process. The bigger consideration is usually continuity of dosing, if you're mid-titration on a specific schedule, your new provider will want your full history to avoid restarting the process from scratch unnecessarily.

The Bottom Line on Ro vs. Hims vs. Shed

Ro and Hims both offer legitimate paths to GLP-1 treatment, and neither is a bad option on paper. But once you compare what's actually included, a consistent named provider, coaching built in rather than upsold, transparent pricing, and formulation flexibility, Shed is the stronger choice for most people weighing these three side by side. The medication itself has become fairly similar across providers in 2026, which means the program built around it is what actually determines whether treatment feels sustainable a year in. That's the piece Shed is built around, and it's the piece Ro and Hims still treat as optional.

FAQs About Ro vs. Hims for GLP-1

Is Ro or Hims cheaper for GLP-1 weight loss?

Pricing changes often and depends on dose, plan length, and whether you're prescribed a compounded or FDA-approved medication. It's worth comparing current published pricing directly on each platform rather than relying on older comparisons.

Do Ro and Hims still offer compounded semaglutide?

Hims moved away from broad compounded semaglutide for new patients in 2026, focusing on FDA-approved options instead. Ro has continued offering compounded semaglutide and tirzepatide, though the space remains under regulatory scrutiny.

Is Shed cheaper than Ro or Hims?

Medication pricing is fairly close across all three providers now that manufacturer self-pay programs have narrowed the gap. Where Shed pulls ahead on value is what's included at that price: coaching, a named provider, and formulation options that Ro and Hims often charge extra for or don't offer at all.

Is Shed better than Ro or Hims?

For most patients, yes. Shed includes health coaching, a consistent named provider, transparent pricing, and non-GLP-1 alternatives as standard parts of the program, rather than add-ons you have to seek out. Ro and Hims are larger and well-established, but that scale often comes at the cost of the continuity and support Shed builds in from the start.

What's the biggest difference between Ro, Hims, and Shed?

Ro and Hims operate at a much larger scale with broader medication catalogs, but that scale comes with more rotating providers and coaching that's usually an add-on. Shed focuses on a smaller, more clinically supported model with a named provider, included health coaching, and formulation options beyond a standard injection, all built in rather than upsold.

Can I switch from Ro or Hims to Shed?

Yes. Switching providers is generally straightforward, and it helps to share your medication history and current dosing schedule with Shed's care team so treatment can continue without unnecessary restarts.

Does Ro or Hims include health coaching?

It varies by plan and has changed over time as both companies adjust their offerings, and it's often a paid add-on rather than a standard feature. Shed includes health coaching in every plan by default, with no separate upgrade required.

Disclaimer:

This content is provided for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. You should consult a licensed healthcare provider for evaluation and guidance specific to your situation before starting or changing any treatment, supplement, or medication.

Ro and Hims are trademarks of their respective companies. This content is intended as a general comparison of publicly available business models and is not sponsored by, affiliated with, or endorsed by Ro or Hims. Pricing, offerings, and regulatory status change frequently and should be verified directly with each provider.

Compounded medications are not FDA-approved for safety, effectiveness, or quality and are only appropriate for patients with a documented clinical need that an FDA-approved product cannot meet.

Shed is not a pharmacy and does not dispense medications. Prescriptions are fulfilled and shipped by a licensed third-party dispensing pharmacy.

‍